A Study to Investigate the Pharmacodynamic and Pharmacokinetic Interaction of LY2216684 With Alcohol in Healthy Subjects.
Phase of Trial: Phase I
Latest Information Update: 19 Sep 2011
At a glance
- Drugs Edivoxetine (Primary)
- Indications Depressive disorders
- Focus Pharmacodynamics; Pharmacokinetics
- 19 Sep 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 18 Jul 2011 Planned end date changed from 1 Aug 2011 to 1 Sep 2011 as reported by ClinicalTrials.gov.
- 08 Jul 2011 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.